Global law firm White & Case LLP has successfully represented Zimmer Holdings, Inc. (renamed Zimmer Biomet Holdings, Inc.), in obtaining regulatory clearance from the US Federal Trade Commission (FTC), European Commission (EC) and Japan's Fair Trade Commission (JFTC) for its $14 billion acquisition of Biomet, Inc., on which the Firm also advised.
Zimmer, a leader in musculoskeletal health solutions, entered into a merger agreement in April 2014 with Biomet, and the acquisition was completed on June 24, 2015 following final approval from the FTC.
In an unprecedented move, the EC gave its approval two months before the formal deadline to complete its investigation, which it launched in October 2014.
Antitrust lawyers from White & Case's Washington, Brussels and Tokyo offices advised Zimmer. The team in Washington was led by partners George Paul and Rebecca Farrington, the team in Brussels was led by partners Mark Powell and Axel Schulz and the team in Tokyo was led by Mangyo Kinoshita. M&A partners Morton A. Pierce, Chang-Do Gong and Robert Chung, all based in New York, advised Zimmer on the acquisition.
For more information please speak to your local media contact.